Giorgio Gandaglia

Jan 10, 2025 | europeanurology.com | Mattia Longoni |Alberto Briganti |Giorgio Gandaglia |Francesco Montorsi

Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes aUnit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, IRCCS San Raffaele Scientific Institute, Milan, Italy b“Vita-Salute” San Raffaele University, Milan, Italy Publication History: Accepted January 2, 2025; Published online January 10,...

Jun 2, 2023 | urotoday.com | Giorgio Gandaglia

Giorgio Gandaglia explores the ongoing clinical trials in the field of prostate cancer, from diagnosis to advanced stages of the disease. He begins by discussing the implementation of PET/CT and MRI in diagnosing prostate cancer and the potential benefits of these tools, including the reduction in clinically insignificant detections and biopsies. Gandaglia highlights the role of novel biomarkers in aiding diagnosis.